SECURITY PLUS LIMITED
Company number 01325489 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: Security Plus Limited
1. Financial Health Score: B-
Explanation: Security Plus Limited presents a mixed clinical picture — robust operational vitality masked by underlying balance sheet fragility. The business demonstrates healthy revenue growth and improving profitability, yet carries dangerously high leverage with rapidly declining liquidity. Like a patient with a strong pulse but elevated blood pressure, the operational engine is performing well, but the financial circulatory system is under significant strain. The acquisition by Pivotal (Tate Group Holdings) in October 2024 provides a corporate "safety net," but the underlying financial structure warrants careful monitoring.
2. Key Vital Signs
Revenue Health: ✅ Strong
| Period | Turnover | Growth |
|---|---|---|
| YE Sep 2020 | £30.3M | - |
| YE Sep 2021 | £25.8M | -15.0% (COVID impact) |
| YE Sep 2022 | £31.0M | +19.9% |
| YE Sep 2023 | £34.4M | +10.9% |
| 18m to Mar 2025 | £53.2M | +4.8% (annualised) |
The strategic report helpfully breaks the 18-month period into comparable chunks: £36.0M for the 12 months to September 2024 represents 4.8% growth over the prior year — steady rather than spectacular, but positive in a challenging inflationary environment.
Profitability: ✅ Improving
| Metric | 18m to Mar 2025 | 12m to Sep 2024 | YE Sep 2023 | Change |
|---|---|---|---|---|
| Gross Profit | £28.4M | £19.2M | £18.6M | +2.97% |
| PBT | £2.97M | £2.11M | £1.47M | +43.2% |
Gross Margin: ~53.4% (18-month period) — healthy for a cash management, logistics and security services business.
Net Margin: ~5.6% (18-month period) — modest but improving significantly. The 43% jump in pre-tax profit year-on-year suggests operational efficiencies are flowing through, likely aided by Pivotal's integration.
Leverage: ⚠️ Critical Concern
| Year End | Total Assets | Total Liabilities | Net Assets | Leverage Ratio |
|---|---|---|---|---|
| Sep 2020 | £8.86M | £12.27M | £1.55M | 138.5% |
| Sep 2021 | £7.26M | £10.35M | £0.65M | 142.6% |
| Sep 2022 | £9.11M | £11.51M | £1.00M | 126.3% |
| Sep 2023 | £8.65M | £11.33M | £1.99M | 131.0% |
| Mar 2025 | £13.59M | £13.10M | £4.20M | 96.4% |
Interpretation: Total liabilities consistently exceed total assets in earlier years — the company has historically been technically insolvent on a balance sheet basis. The March 2025 position shows significant improvement with net assets of £4.2M, but the leverage ratio of 96.4% means liabilities still consume virtually all assets. This is the financial equivalent of a patient carrying dangerous weight — functional, but with minimal buffer for shocks.
The improvement from £0.65M net assets (2021) to £4.2M (2025) is encouraging and likely reflects capital injection or debt restructuring associated with the Pivotal acquisition.
Liquidity: 🔴 Acute Concern
| Year End | Cash | Change |
|---|---|---|
| Sep 2020 | £3.56M | - |
| Sep 2021 | £2.16M | -39.2% |
| Sep 2022 | £2.26M | +4.6% |
| Sep 2023 | £2.70M | +19.7% |
| Mar 2025 | £0.59M | -78.3% |
Interpretation: This is the most alarming vital sign. Cash has plummeted by £2.1M (78%) despite the company generating £2.97M in pre-tax profits over the 18-month period. This represents extremely poor cash conversion — the business is profitable on paper but haemorrhaging cash in reality.
Possible explanations include: - Heavy capital investment (fleet modernization noted in strategic report) - Debt repayment or restructuring costs - Working capital pressures from rapid growth - Acquisition-related transaction costs
Net Asset Trajectory: ✅ Positive Trend
| Year End | Shareholders' Funds | Growth |
|---|---|---|
| Sep 2020 | £1.55M | - |
| Sep 2021 | £0.65M | -58.1% |
| Sep 2022 | £1.00M | +53.2% |
| Sep 2023 | £1.99M | +99.0% |
| Mar 2025 | £4.20M | +111.0% |
Shareholders' funds have more than doubled in the latest period, suggesting capital restructuring or retained profits — likely a combination of both given the acquisition context.
3. Diagnosis
Overall Condition: Operationally Healthy, Financially Vulnerable
Security Plus Limited presents the classic symptoms of a growth business under leverage strain. The diagnosis is akin to an athlete performing at high intensity but with dangerously low reserves — impressive output, but one unexpected shock could prove critical.
Positive Findings: - Revenue momentum is strong and consistent, recovering well from the 2021 dip - Profitability transformation is underway with PBT more than doubling on an annualised basis - Gross margins of ~53% indicate good pricing power and service differentiation - Strategic backing from Pivotal provides access to capital, governance, and operational synergies - Net asset position has improved dramatically, suggesting balance sheet restructuring
Concerning Symptoms: - Critical cash depletion — £2.1M cash burn despite profitable operations indicates severe cash conversion problems - Extreme leverage — 96.4% of assets are consumed by liabilities, leaving minimal equity buffer - Historical technical insolvency — the company operated with negative net assets for years, suggesting reliance on creditor support or group backing - Share capital of £400K is modest relative to the business scale, indicating limited equity cushion - Director changes — multiple resignations in January 2026 (post period-end) including the secretary and two directors, suggests governance restructuring following acquisition
The Pivotal Factor: The October 2024 acquisition by Tate Group Holdings t/a Pivotal is the defining contextual element. The strategic report explicitly references benefits including "enhanced governance," "synergies in technology and fleet management," and "access to group resources." This parent company support is both a strength (providing a financial safety net) and a signal of dependency — Security Plus may not be viable as a standalone entity given its leverage position.
The change in accounting reference date from September to March (aligning with Pivotal's year-end) and the 18-month reporting period are typical post-acquisition adjustments that complicate year-on-year analysis but are administratively normal.
4. Recommendations
Immediate Priority: Stabilise Cash Flow
- Cash Conversion Audit — Conduct a thorough analysis of why £2.97M in reported profits translated to only £0.59M in cash. Identify whether this is investment-related (positive) or operational drain (concerning).
- Working Capital Management — Review debtor days, creditor days, and stock/inventory cycles. With £53M turnover, even small improvements in working capital efficiency could release significant cash.
- Debt Structure Review — Understand the composition of £13.1M in liabilities. Are there opportunities to renegotiate terms, extend maturities, or convert short-term obligations to longer-term facilities?
Medium-Term: Strengthen Balance Sheet
- Capital Injection — Consider whether Pivotal should inject additional equity to reduce leverage and provide a more robust financial foundation. The current 96.4% leverage ratio leaves virtually no room for error.
- Asset Utilisation Review — Total assets grew from £8.65M to £13.59M — a £4.94M increase. Understand whether this represents productive investment or balance sheet inflation that isn't generating proportionate returns.
- Dividend Policy — The report confirms no dividends for the period. This is appropriate given the cash position, but should remain the policy until cash reserves are rebuilt to at least £2M+.
Strategic: Leverage Group Benefits
- Synergy Realisation — The strategic report identifies fleet and technology synergies. Prioritise these to drive margin improvement and cost reduction.
- Governance Integration — The recent director resignations suggest ongoing restructuring. Ensure appropriate governance expertise is retained, particularly financial oversight given the leverage position.
- KPI Dashboard — Implement monthly monitoring of cash conversion ratio, current ratio, and leverage ratio. The current cash position demands real-time visibility rather than retrospective analysis.
Prognosis
Short-term (12 months): Guarded but stable. The Pivotal acquisition provides a safety net that prevents acute financial distress, but the underlying leverage and cash position create vulnerability. Successful integration and cash flow management will be critical.
Medium-term (2-3 years): Cautiously optimistic IF the company can translate operational improvements into cash generation. The trajectory of improving profitability is encouraging, but must be accompanied by cash conversion to be sustainable.
Key Risk: Any disruption to cash flow — whether from contract loss, payment delays, or unexpected costs — could quickly become critical given the minimal cash buffer and high leverage. The parent company backing mitigates this risk but doesn't eliminate it.